A detailed history of Marshall Wace, LLP transactions in Baxter International Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 7,344 shares of BAX stock, worth $216,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,344
Previous 47,810 84.64%
Holding current value
$216,648
Previous $1.6 Million 82.61%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $1.33 Million - $1.63 Million
-40,466 Reduced 84.64%
7,344 $278,000
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $1.57 Million - $2.08 Million
47,810 New
47,810 $1.6 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $5.19 Million - $6.37 Million
-163,584 Reduced 54.79%
134,990 $5.22 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $202 Million - $267 Million
-5,415,839 Reduced 94.78%
298,574 $11.3 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $10.6 Million - $12.7 Million
-265,373 Reduced 4.44%
5,714,413 $260 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $123 Million - $172 Million
3,271,267 Added 120.78%
5,979,786 $243 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $7.77 Million - $9.02 Million
156,241 Added 6.12%
2,708,519 $138 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $136 Million - $169 Million
2,525,732 Added 9514.55%
2,552,278 $137 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $57.5 Million - $72 Million
-900,104 Reduced 97.14%
26,546 $1.71 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $65.8 Million - $76.6 Million
855,801 Added 1207.92%
926,650 $71.9 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $3.21 Million - $3.75 Million
43,015 Added 154.54%
70,849 $6.08 Million
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $2.24 Million - $2.45 Million
27,834 New
27,834 $2.24 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $32.2 Million - $35.2 Million
-427,578 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $21.1 Million - $24.4 Million
-269,236 Reduced 38.64%
427,578 $34.4 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $33.9 Million - $40.6 Million
430,791 Added 161.94%
696,814 $60 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $48 Million - $62.6 Million
-671,229 Reduced 71.62%
266,023 $21.6 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $17.8 Million - $20.5 Million
231,869 Added 32.87%
937,252 $78.4 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $32.4 Million - $35.7 Million
397,799 Added 129.33%
705,383 $61.7 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $21.8 Million - $24.4 Million
296,353 Added 2638.71%
307,584 $25.2 Million
Q1 2019

May 14, 2019

SELL
$64.48 - $81.31 $41.7 Million - $52.6 Million
-646,602 Reduced 98.29%
11,231 $913,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $20.5 Million - $26 Million
333,999 Added 103.14%
657,833 $43.3 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $12.6 Million - $13.9 Million
-178,360 Reduced 35.52%
323,834 $25 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $31.1 Million - $37 Million
490,419 Added 4164.92%
502,194 $37.1 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $13.9 Million - $16.1 Million
-222,824 Reduced 94.98%
11,775 $766,000
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $14.4 Million - $15.5 Million
234,599
234,599 $15.2 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.